Junki Mizusawa

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

Kazumasa Fujitani, Han‐Kwang Yang, Junki Mizusawa et al. · The Lancet Oncology · 2016 · 700 citations

Medicine, Oncology, Surgery +12

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

Kenji Suzuki, Hisashi Saji, Keiju Aokage et al. · Journal of Thoracic and Cardiovascular Surgery · 2019 · 497 citations · Full text

Medicine, Clinical Sciences, Surgery +11

Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212)

Shin Fujita, Junki Mizusawa, Yukihide Kanemitsu et al. · Annals of Surgery · 2017 · 446 citations · Full text

Medicine, Oncology, Surgery +16

Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912

Hitoshi Katai, Junki Mizusawa, Hiroshi Katayama et al. · Gastric Cancer · 2016 · 391 citations · Full text

Medicine, Oncology, Surgery +16

Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial

Shin Fujita, Takayuki Akasu, Junki Mizusawa et al. · The Lancet Oncology · 2012 · 362 citations

Medicine, Oncology, Surgery +16